1. Overview of genus *Lachesis* {#sec1}
===============================

Genus *Lachesis* ([@bib55]) (Viperidae: Crotalinae), commonly called in Brazil "Surucucu-pico-de-jaca" and in other countries "Bushmaster". With the largest known specimens reaching 3.05--3.36 m ([@bib15]), 3.35 m ([@bib61]), 3.5 m ([@bib1]), 4.27 m ([@bib64]), and 4.5 m ([@bib97]), bushmasters comprises the longest snakes in the Western Hemisphere, and the longest vipers (Viperidae: Crotalidae) in the world. *Lachesis* taxa are the only oviparous species ([Fig. 1](#fig1){ref-type="fig"}B) among New World vipers ([@bib30]; [@bib125]). They lay up to 20 eggs to which the female provides parental care curling up in the eggs to protect them ([@bib62]; [@bib127]) ([Fig. 1](#fig1){ref-type="fig"}A). It has also been reported that females remain with eggs until hatching, and that males stay close to females for some time after mating ([@bib67]).Fig. 1*Lachesis* sp in different behaviors. (A) Parental care of a *L. stenophrys* female along with the eggs ([@bib44]) (B) A neonate of *L. acrochorda* that just hatched ([@bib54]). Photos kindly provided by Greivin Corrales.Fig. 1

The four nominal species within *Lachesis* are nocturnal terrestrial venomous pit vipers found in primary and secondary forested areas of Central and South America and on the island of Trinidad ([@bib30]; [@bib125]; [@bib192]). The Central American bushmaster, *L. stenophrys* ([@bib41]), is endemic to the Caribbean coast of Central America; the black-headed bushmaster, *L. melanocephala* ([@bib172]) has an extremely limited distribution restricted to the Corcovado. National Park along the Pacific coast of southwestern Costa Rica, and possibly in the extreme western part of Panama. The Chocoan bushmaster L. *acrochorda* ([@bib79]) ranges in both the Atlantic and Pacific versants of western Panama and into northwestern Colombia, on the Atlantic coast where it extends southward into the Cauca and Magdalena river Valleys, and along the Pacific versant of Colombia into northwestern Ecuador. Among the two subspecies of *L. muta* ([@bib110]), the nominal subspecies, the South American bushmaster (*L. muta muta*), can be found in South America in the equatorial forests east of the Andes and the island of Trinidad, and the Atlantic Forest bushmaster, *L. muta rhombeata* ([@bib185]) inhabits Coastal forests of southeastern Brazil, from southern Rio Grande do Norte to Rio de Janeiro ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2**Geographic distribution of the genus *Lachesis* in Central and South America.***L. muta muta* (red: highest medical importance, and in orange: secondary medical importance) distributed in the following countries: Venezuela, Colombia, Trinidad and Tobago, Guyana, Suriname, French Guiana, Ecuador, Perú, Bolivia and Brazil (in the States: Goiânia, Mato-Grosso, Tocantis, Para, Amazonas, Rondônia, Acre, Amapá, Roraima and Maranhão). Photo: Paulo Sérgio Bernarde. *L. m. rhombeata* (blue), found in Coastal forest of southeastern Brazil (Ceara, Rio de Janeiro, Paraíba, Pernambuco, Bahia, Espirito Santo, Minas Gerais, Alagoas and Rio Grande do Norte). *L. acrochorda* (green) found in the countries: Panamá, Colombia e Ecuador. Photo: Jairo Maldonado. *L. stenophrys* (yellow) found in Costa Rica and Panamá. Photo: Instituto Clodomiro Picado. *L. melanocephala* (gray) found in Costa Rica. Photo: Jaime Culebras. Maps taken from (World Health Organization) (<https://apps.who.int/bloodproducts/snakeantivenoms/database/>).Fig. 2

The Central and South American forms diverged 18--6 Mya, perhaps due to the uplifting of the Andes, whereas the two Central American subspecies may have diverged 11--4 Mya with the uprising of the Cordillera de Talamanca that separates them today ([@bib192]). The split between Central American L. *melanocephala* and *L. stenophrys* is estimated to have taken place 11--4 Mya, and differentiation among the South American lineages happened only 800,000 to 300,000 years ago ([@bib71]; [@bib192]) ([Fig. 3](#fig3){ref-type="fig"}).Fig. 3Phylogenetic tree of genus *Lachesis* highlighting the estimated divergence time between the Central and South American taxa ([@bib192]), the remarkably similar overall venom compositional profiles among the five species of Central and South American bushmasters ([@bib138]; [@bib157]), and the ontogenetic changes in the venom composition of *L. stenophrys* ([@bib115]). La, *L. acrochorda*; Lme, *L. melanocephala*; Lmm, *L. muta muta*; Lmr, *L. m. rhombeata*; Ls, *L. stenophrys.* Acronyms = VAP: BPP, bradykinin-potentiating peptide, and C-NP, type natriuretic peptide; D49-PLA~2~, Asp49 phospholipase A~2~; SP, snake venom serine proteinase; LAO, L-aminoacid oxidase; SVMP, snake venom metalloproteinase; CTL: Gal lectin, galactose-specific lectin; svVEGF, snake venom vascular endothelial growth factor; CRISP, cysteine-rich secretory protein. Phylogenetic scheme adapted from Fig. 5 ([@bib23]), kindly provided by Professor Juan Calvete.Fig. 3

Bushmaster can live long. There are records of a male of *L. m. muta* that lived for more than 16 years in captivity at the Fort Worth Zoo and a specimen of *L. stenophrys* that lasted 31 years and 7 months at the Atlanta Zoo ([@bib169]). [@bib30] also mention an *L. stenophrys* from Costa Rica, kept for almost 30 years in Europe. However, there are no data on longevity in its natural ecosystem.

Bushmasters prey primarily on small mammals, such as rodents and marsupials ([@bib14]; [@bib45]; [@bib124]; [@bib126]; [@bib127]), but also hedgehog ([@bib75]), birds and amphibians ([@bib33]). Although the specimens examined were adults, the prey was relatively small. Juvenile snakes (and some adults) maintain control when attacking prey, and an epicantic fold protects the eyes from possible damage during predation. Juvenile individuals may have the tip of the tail bright orange or yellow, but tail movements to attract prey (\"tail luring\") has not been reported ([@bib146]).

Lachesis, daughter of Erebus (Darkness) and Nyx (Night), is a goddess who in the Greek mythology assigned individual destinies to mortals at birth. This epithet given to the homonymous genus may refer to the feeling that during an encounter with these imposing snakes one\'s own fate is momentarily at the snake\'s will. However, human envenomings by *Lachesis* taxa are infrequent as these snakes do not exhibit aggressive behavior, inhabit shelters in fallen trees, burrows and excavations of rodents or in rocky caves of remote forest area ([@bib73]), where contact with man is scarce ([@bib175]). *Lachesis* have nocturnal habits, remaining throughout the day in a state of torpor. Only in the breeding season, males are on day alert and ready for combat. In addition, venom lethality is weak compared to those of some other vipers ([@bib17]; [@bib46]). [@bib22] quote the following LD50 values of *L. m. muta* venom for mice: 1.5 mg/kg (intravenous), 1.6--6.2 mg/kg (intraperitoneal) and 6.0 mg/kg (subcutaneous). Nevertheless, human envenomings can be rather severe due to the large venom yield (200--411 mg) ([@bib22]; [@bib121]).

Venomics studies have been conducted on all species and subspecies within genus *Lachesis* ([@bib115]; [@bib138]; [@bib157]). Comparison of their venom proteomes provided an overview of the geographic and ontogenetic variation of the toxic arsenal across genus *Lachesis.* Hence, notwithstanding minor qualitative and quantitative differences, the venom arsenals of *L. melanocephala* and *L. acrochorda* are broadly similar between themselves and also closely mirror those of adult *L. stenophrys* and *L. muta* venoms. On the other hand, the toxin composition of *L. stenophrys* venom undergoes ontogenetic changes, which involve changes in the concentration of vasoactive peptides and serine proteinases, which steadily decrease from birth to adulthood, and age-dependent biosynthesis of Gal-lectin and snake venom metalloproteinases (SVMPs). The net result is a shift from a bradykinin-potentiating and C-type natriuretic peptide (BPP/C-NP)-rich and serine proteinase-rich venom in newborns and 2-years-old juveniles to a (PI \> PIII) SVMP-rich venom in adults ([@bib115]). The venom of newborn *L. stenophrys* has lower toxicity to mice than venom from older conspecific snakes ([@bib89]). However, bites by a 10 to 14-day-old and a 2-month-old *L. stenophrys* specimens produced substantial toxicity to humans, which similar to an adult bite completely overwhelmed the 80 kg victim within 30 min ([@bib145]). The venomics analysis of neonate and juvenile *L. stenophrys* suggests that the high content of vasoactive peptides and serine proteinases may be responsible for the high toxicity of newborn venom in humans. On the other hand, the high similarity of their venom proteomes is mirrored by a high immunological conservation across the genus ([@bib138]). A corollary of this fortunate circumstance is that antivenoms generated against venom mixtures containing any *Lachesis* spp. venom may exhibit paraspecific protection against ([@bib49]; [@bib56]) the toxic activities of venoms from any other congeneric species ([@bib114]).

Adaptations result from selective pressures on both morphological and molecular phenotypic traits that maximize the organism\'s fitness in local environments, e.g., the snake foraging success on preferred prey. Venom is an intrinsically ecological trophic trait crucial for the foraging success of the organisms that produce it. Hence, functional evolution of venoms is intimately linked to the ecology and dietary habits of the venomous organisms. A still small but increasing number of studies support the idea that snake venom evolution is driven by diet-related selection pressures leading to local adaptations ([@bib12]; [@bib13]; [@bib49]; [@bib56]; [@bib100]; [@bib170]). Consequently, the changes in toxic characteristics of venom that ocurr during the development of *L. stenophrys* ([@bib115]), should be rationalized in the context of its use by the venomous predator. Optimal foraging theory predicts that juvenile gape-limited predators should feed efficiently in order to compete with adults for food ([@bib161]) and to minimize their exposure to predators ([@bib164]). [@bib32] predicted that juvenile animals should compensate for their small size by increasing their overall performance relative to adults (compensation hypothesis, e.g. decreased ingestion and/or handling times relative to body size compared with adults). In line with this view, concomitantly with age-dependent venom compositional changes, newborn *L. stenophrys* venom showed highest coagulant effect on human plasma, in line with its high serine proteinase content, whereas the venom lethal, proteolytic, hemorrhagic, edema-forming, myotoxic, and PLA~2~ activities raise as snakes aged ([@bib89]). The different pharmacological effects of venom from neonate and adult individuals is mirrored by clinical reports indicating that human envenomings by juvenile specimens are often associated to prominent alterations and symptoms despite the low amount of venom that a small size specimens may inject in a bite ([@bib37]; [@bib92]). Neonate L. *stenophrys* specimens produce substantial toxicity to humans, which similar to an adult bite completely overwhelmed an 80 kg victim within 30 min ([@bib145]). The proteomic analysis of ontogenetic changes in *L. stenophrys* venom suggests that the high content of vasoactive peptides and serine proteinases may be responsible for the high toxicity of newborn *L. stenophrys* venom in humans ([@bib115]).

Age-related changes in venom composition, as it happens in *L. stenophrys*, have been reported in a number of New World pit viper species from different genera, i.e. *Crotalus*, *Bothrops*, *Sistrurus*, and *Bothiechis* ([@bib4]; [@bib28], [@bib27]; [@bib80]; [@bib82]; [@bib86]; [@bib112]; [@bib139]; [@bib149]; [@bib194], [@bib195], [@bib193]). A similar pattern was noted for the Brown Treesnake (*Boiga irregularis*), with juvenile venoms more toxic than adult venoms towards geckos ([@bib113]), suggesting that this trend has not exclusively evolved in pit vipers. A shift in the feeding habits of juvenile versus adult snakes, from cold-blooded (arthropods, frogs and lizards) to warm-blooded (mammals) prey, has been invoked to explain the ontogenetic venom change in some pitviper species ([@bib8]). In concordance with this view, it has been documented that venoms from neonate snakes are more toxic to lizards and inbred mice than adult venoms ([@bib112]). Young *Bothrops* snakes preferentially eat amphibians, lizards, birds, and shift to mammals when they become adults ([@bib30]). However, *Lachesis* taxa feed from birth on vertebrates, primarily rodents (i.e., brown mice (*Akodon*), rice rats (*Oryzomys*), spiny rats (*Proechimys*)) and marsupials of the family Didelphidae ([@bib30]). Similarly, the venom composition of the Central American rattlesnake, *Crotalus simus*, a species that feeds from its birth primarily on small rodents and lizards ([@bib27]), changes dramatically during development, from a neurotoxic to a hemorrhagic phenotype, and these ontogenetic changes appears to be post-transcriptionally modulated by miRNAs ([@bib65]). Predator body size is one of the most important factors shaping predator--prey interactions ([@bib100]; [@bib134]; [@bib135]), and dietary decisions define the trophic niche of the organism and have significant implications on the individual\'s energy budget. Ontogenetic venom composition shift resulting in a different pharmacological venom profile, may fulfill the requirements to subdue prey of different sizes and initiate its digestion may change with the size of both the predator and the prey. This is particularly important when a large prey (in relation to the snake\'s digestive apparatus size) is ingested. Biochemical features of venom that enhance trophic functions are likely very important for snakes. It has been hypothesized that tissue-degrading enhancement of venom may facilitate efficient prey digestion at suboptimal temperatures encountered in the field, thereby reducing the risk of prey putrefying before it can be digested ([@bib178]). Putrefaction forces a snake to regurgitate its prey, which had been swallowed whole, head first without mastication. Regurgitation can thus be a severe, and in some instances a life-threatening problem ([@bib72]). Injection of proteolytic venom may hasten the entrance of the acidic secretions of the snake\'s stomach into the prey\'s gut, reducing or eliminating the action the putrefactive bacteria ([@bib178]). It is therefore not unreasonable to suggest that he high amounts of histolytic enzymes contained in the venom of newborn *L. stenophrys* snakes may serve to breakdown the bolus, contributing to reduce the chances of putrefaction of the ingested prey.

2. Lachesis envenoming: epidemiology, symptoms and treatment {#sec2}
============================================================

Snakebites by front-fanged snakes is an occupational disease that cause envenomings to at least 1.8--2.7 million people worldwide per year, with combined upper WHO estimates of mortality ranging from 81,000 to 138,000 deaths, and maims \>400,000 people every year ([@bib38]; [@bib39]; [@bib91]; [@bib188]). The only scientific validated treatment of snakebite envenoming is the timely administration of an effective antivenoms ([@bib90]; [@bib94], [@bib95]). One of the greatest limitations for developing effective interventions for snakebite envenomation is the paucity of reliable information on incidence and mortality ([@bib93]). A recent report on data gathered from Ministries of Health the specialized literature identified a total of 57,500 snakebite cases in the Americas, 370 of which resulted in death ([@bib40]). However, due to the limitations of the information systems in many countries where snakebite reporting is not compulsory, these figures are likely to be underestimations.

In Brazil, snakebites are mainly associated with agricultural work and, in the Amazon region, also with extractive activities ([@bib196]; [@bib68]; [@bib136]; [@bib183]). Approximately 29,000 cases of snakebite accidents are reported each year by the SINAN (Reporting Disease Information System), with an average of 129 yearly deaths (0.44% lethality) ([@bib16]). According to data from the Ministry of Health, 939 laquetic accidents were reported in Brazil in the period 1990--1993. This figure is equivalent to 1.4% of the total envenomings caused by venomous snakes in Brazil ([@bib19]). Another study carried out from 2001 to 2015 reported 13,044 accidents (84 deaths) by the *Lachesis* taxa, i.e. approximately 869 accidents per year ([@bib119]). In the Amazon region bites caused by *Lachesis* taxa in the period 2010--2015 were responsible for 5217 cases, only superated by envenomations caused by snakes of genus *Bothrops* (57,374 cases, 81.02%, including a high proportion of deaths (74.48%) and amputations (86.88%) among the victims) ([@bib120]). In line with these data, a recent study by da Silva and coworkers (2020), conducted in the Alto Juruá, a region in the western Brazilian Amazonia, also reported low frequency of accidents caused by *Lachesis* snakebites. Despite these data, in the same study da Silva and coworkers (2020) investigated the ethnobiological perception of dangerousness of different snake species by the population of the rural areas of Alto Juruá. Interviews to 100 villagers active in the forests revealed that *L. muta muta* was considered the most dangerous venomous snake, and *B. atrox* appeared to be the most feared snake species. The authors interpreted that the high incidence, severity, and mortality of *B. atrox* bites and the severity and mortality of *L. muta* bites represented the factors that contributed to these species being perceived as the most feared and venomous snakes, respectively. This villagers\' perception reflects the fact that although encounters with human are infrequent owing to their little aggressive behavior and elusive ecological habits, envenomings by *Lachesis* taxa are characterized by the high amounts of venom inoculated, (200--411 mg) ([@bib22]; [@bib121]), which makes bite by bushmasters serious and result in high rates of permanent sequelae and mortality ([@bib129]; [@bib152]; [@bib177]).

The symptoms of envenomations caused by *Lachesis* taxa can be similar to those observed in bothropic envenomings, i.e. local pain, edema, hemorrhage and myonecrosis. Distinct features of bites by *Lachesis* taxa are agonizing burning-throbbing local pain and edema, within the first few minutes after the bite, followed within the next within 15--20 min by a "vagal symptomatology" characterized by profuse sweating, abdominal colic, nausea, recurrent vomiting, watery diarrhea, diastolic and systolic hypotension, sinus bradycardia, uncoordinated march, lapses of consciousness ([@bib165]; [@bib184]). The vagal syndrome, may assists in the differential diagnosis between laquetic and bothropic accidents ([@bib58]; [@bib177]). Laquetic accidents are classified according to their clinical manifestations as i) Mild: mild or absent edema and mild or absent hemorrhagic manifestations. Absence of vagal manifestations; ii) Moderate: with evident edema and discrete hemorrhagic manifestations at a distance (gingivorrhagia, epistaxis). Absence of vagal manifestations; and iii) Severe: presence of severe edema and systemic manifestations such as profuse hemorrhage. Presence of vagal manifestations (diarrhea, bradycardia, hypotension or shock) ([@bib174]) ([Table 1](#tbl1){ref-type="table"}). In Brazil, treatment of laquetic envenoming is based on the severity of the accident, administering when necessary the Brazilian Soro Antibotrópico-Laquético (SABL) intravenously ([@bib20]; [@bib130]). The antivenom, manufactured at Instituto Butantan (São Paulo, Brazil), is obtained from the plasma of horses hyperimmunized with a mixture of venoms from five species of snakes of genus *Bothrops* (*B. jararaca* (50%), *B. jararacussu* (12.5%), *B. moojeni* (12.5%), *B. alternatus* (12.5%) and *B. neuwiedi* (12.5%) and from the plasma of horses hyperimmunized with venom of *L. muta*. The final formulation consists of purified F(ab\')~2~ fragments generated by digestion with pepsin of ammonium sulphate-precipitated IgG molecules. A vial of SABL (10 mL) nominally neutralizes at least 50.0 mg of *B. jararaca* venom (the reference venom for assessing the bothropic antivenom potency in Brazil) and no less than 30 mg of the *L. muta* reference venom ([@bib19]; [@bib128]; [@bib142]).Table 1Serotherapy and clinical manifestations of laquetic accidents.Table 1ACTIVITYCLASSIFICATION AND INITIAL CLINICAL EVALUATIONSerotherapy No. of ampoulesModerateSevere1020Route of administrationEndovenousAcute inflammatoryEndothelial injury and necrosis at the bite site. Release of inflammatory mediators.CoagulantBlood incoagulabilityHemorrhagicBleeding in the bite region (ecchymosis) and at distance (gingival, hematuria).Vagal neurotoxicCholinergic stimulation (vomiting, abdominal pain, diarrhea, hypotension, shock).(Source: adapted from Brazil, 2019)

Key technical issues concerning the generation of an antidote for snakebite envenoming are i) the design of the immunization mixture in such a way that the resulting antivenoms results effective against most venoms of the medically-relevant snake species within the geographical range where these antivenoms is intended to be used, and ii) a reliable taxonomy. This purpose is not trivial given the well-documented occurrence of venom variability at all the taxonomic levels (genus, species, subspecies, population and individual) ([@bib25]) and the instability of the phylogeny of certain snake clades ([@bib31]). In addition, the rational generation of polyvalent antivenoms of broad clinical spectrum require a deep understanding of the toxicovenomics profile of the target venoms ([@bib88]). Toxicovenomics refers to the screening of individual venom fractions of a toxin-resolved chromatographic profile for specific toxic activities ([@bib105]; [@bib111]). Genus *Lachesis* meets these criteria for what we can consider it a prospective model system to define knowledge-based omics strategies ([@bib26], [@bib29]) for the production of next-generation pan-generic antivenoms.

3. Bioactive components of *Lachesis* venom {#sec3}
===========================================

*Lachesis m. muta* venom gland transcriptomic analysis ([@bib102]) and proteomic analyses of the venoms of all the nominal species and subspecies within genus *Lachesis: L. m. muta*, ([@bib157]); *L. m. rhombeata* ([@bib138]); *L. stenophrys*, *L. acrochorda*, and *L. melanocephala* ([@bib115]), have provided a genus-wide insight into the overall complexity of their toxic arsenals. Bushmaster venoms comprise a relatively conserved set of proteins and peptides, belonging to just a few major (i.e. relative abundances between 10 and 30% of the total venom proteome: bradykinin-potentiating peptides; snake venom serine proteinases; PIII- and PI-snake venom metalloproteinases; and PLA~2~) and minor (L-aminoacid oxidase; galactose-specific lectin; vascular endothelial growth factor; cysteine-rich secretory protein; phospholipase B; and hyaluronidase) toxin families ([Fig. 2](#fig2){ref-type="fig"} and [Fig. 4](#fig4){ref-type="fig"}). Pairwise comparisons showed overall similarities of 33--51% across the different conspecific venom proteomes ([@bib138]), with PLA~2~ showing the greatest interspecific variability ([@bib157]). Despite the wealth of low-resolution proteomics and biochemical information available ([Table 2](#tbl2){ref-type="table"}) ([@bib21]; [@bib52]), the timing and relevance of individual venom proteins and overall venom proteome divergence in the mechanisms of adaptation to local ecosystems and speciation of the Bushmasters remains elusive.Fig. 4Distribution of *Lachesis* venom toxin families from which individual toxins have been isolated and charaterized ([Table 2](#tbl2){ref-type="table"}). Toxin families are represented as gray bars and the different color lines refer to the species/subspecies. Discontinuous gray lines indicate absence of data on isolated toxins from the *Lachesis* taxa labeled with an asterisk.Fig. 4Table 2Main components characterized in venoms of the genus *Lachesis.*Table 2NAMESPECIEPROTEIN/PEPTIDEMOLECULAR\
MASS (kDa)BIOLOGICAL PROPERTIESTHERAPEUTIC POTENTIALREFERENCESLmrBPP9*L. m. rhombeata*Bradykinin-potentiating peptides (BPP)1.08Inhibit ACE activity *in vitro*Hypotensive effect[@bib137]Lmr-MP*L. m. rhombeata*Metalloproteinase22.85Proteolytic activity on synthetic substrate of human kallikrein--[@bib42]LmrSP-4*L. m. rhombeata*Serine proteinase28.19Aα- fibrinogenolytic;\
Proteolytic activity on synthetic substrate of human kallikrein--[@bib186]LmrLEC-1*L. m. rhombeata*C-type lectin\~14----[@bib186]LmuTX*L. m. muta*PLA~2~ Lys-4913.8Cytotoxicity on C2C12 cells differentiated in myotubesAntibacterial activity against strains of MRSA and *Pseudomonas aeruginosa*[@bib59]LmLAAO*L. muta*L-amino acid oxidase (LAAO)60Without myotoxic activities, hemorrhagic and edematogenicCytotoxic activity on AGS and MCF-7 cells; *L. braziliensis* activity[@bib21]Stenoxobin*L. stenophyrs*Serine proteinase (thrombin-like)37α and β- fibrinogenolytic--[@bib10]LsPA-1*L. stenophyrs*PLA~2~ Asp4913.87----[@bib57]LmTX-I*L. m. muta*Basic PLA~2~ Asp4914.24Phospholipase activity on synthetic substrates; edema; myotoxicity; neurotoxicity--([@bib51], [@bib50], [@bib52])LmTX-II*L. m. muta*Basic PLA~2~ Asp4914.18Phospholipase activity on synthetic substrates--[@bib52]LmrTX*L. m. rhombeata*Basic PLA~2~ Asp4914.27Anticoagulant and antithrombotic activities--[@bib53]Lmr-PLA~2~*L. m. rhombeata*Acidic PLA~2~ Asp4913.97Inhibition of platelet aggregation--[@bib43]LV-Ka*L. m. muta*Serine proteinase (calicreína-símile)33Plasminogen activation--[@bib69]LM-PLA~2~-I*L. muta*Acidic PLA~2~ Asp49--Myotoxicity--[@bib77]LM-PLA~2~-II*L. muta*Acidic PLA~2~ Asp4918Myotoxicity; inhibition of platelet aggregation; edematogenic activity.--([@bib76], [@bib78])TLE-B*L. m. muta*Serine proteinase44α and β- fibrinogenolytic.--[@bib117]TLB-P*L. m. muta*Serine proteinase43α and β- fibrinogenolytic.--[@bib117]Mutalisin I (LHF-I)*L. m. muta*Metalloproteinase100α and β-fibrinogenolytic; high hemorrhagic activity; caseinolytic activity.--([@bib150], [@bib153])Mutalisin II (LHF-II)*L. m. muta*Metalloproteinase22Degradation of laminin, fibronectin and type IV collagen; edematogenic; low hemorrhagic activity.Thrombolytic effect([@bib2]; [@bib148]; [@bib154])Mut IIa*L. m. muta*Mutalisin isoform II≈23α and β- fibrinogenolytic; proteolytic activity on dimethylcasein.--[@bib156]Mut IIb*L. m. muta*Mutalisin isoform II≈23α e β-fibrinogenolítica; proteolytic activity on dimethylcasein.--[@bib156]Hyaluronidase*L. m. rhombeata*Hyaluronidase60----[@bib187]PLB*L. m. rhombeata*Phospholipase B------[@bib187]LMR-47*L. m. rhombeata*Serine proteinase (gyroxin)47α - fibrinogenolytic--[@bib3]Protein similar to lectin*L. stenophyrs*Lectin16.2Hemagglutination--([@bib11]; [@bib9])Lachesin*L. muta*Disintegrin--Inhibition of platelet aggregation; binding to integrin αIIbβ3--[@bib159]LSF*L. stenophyrs*Metalloproteinase24----[@bib106]Serine proteinase*L. m. muta*Serine proteinase45----[@bib118]Kininogenin*L. muta*Serine proteinase29.7Hypotensive effect[@bib60]Gyroxin*L. m. muta*Serine proteinase≈60High lethality--[@bib47]Thrombin-like*L. m. muta*Serine proteinase≈41-47Fibrinogenolytic--[@bib167]Serine proteinase*L. m. muta*Serine proteinase40α and β- fibrinogenolytic--[@bib189]Arginine esterase*L. muta*--≈30Arginyl esterase activity--[@bib166]BIP*L. muta*Bradykinin inhibitor1.06Inhibitory activity on bradykinin via B2 receptors--[@bib84]βPLIs*L. muta*Beta-type inhibitors PLA~2~s36.5----[@bib108]LNF1 and LNF2*L. m. muta*Gamma-type inhibitors\
PLA~2~s≈20----[@bib74]Thrombin-like/analogous to gyroxin*L. m. muta*Serine proteinase25.6----[@bib116]LV-PA*L. m. muta*Serine proteinase33Plasminogen activation--([@bib151], [@bib155])Lm-BPP 1 to 5 and Lm-CNP*L. muta*BPPs and C-type natriuretic peptides1 a 2.2----[@bib171]

[Table 2](#tbl2){ref-type="table"} lists molecules characterized in *Lachesis* venoms. Most of these proteins are myotoxins, neurotoxins, anticoagulant and antithrombotic PLA~2~s, thrombin-like, gyroxin and kallikrein serine proteinases, and hemorrhagic PIII-metalloproteinases, including *L. m. muta* LHF-I and II and a new P-1 class metalloproteinase (Lmr-MP) isolated from the venom of *L. m. rhombeata* venom ([@bib42]). Other toxins, include serine proteinase (LmrSP-4), type C lectin (LmrLEC-1) ([@bib186]) and bradykinin-potentiating peptides ([@bib137]). However, little is known about the biological roles of these proteins and peptides in the mechanisms underlying *Lachesis* envenoming. Furthermore, there are few superficial investigations on the biotechnological potential of *Lachesis* venom components, with biological activities mainly restricted to hypotensive effect ([@bib60]; [@bib137]), thrombolytic activity ([@bib2]; [@bib148]; [@bib154]), antimicrobial activity against methicillin-resistant strains of *Staphylococcus aureus* (MRSA) and *Pseudomonas aeruginosa* ([@bib59]), and antiparasitic activity against *Leishmania braziliensis* ([@bib21]).

4. Concluding remarks and perspectives {#sec4}
======================================

Bushmaster are important components of tropical ecosystems. However, our understanding of the details of their natural history, ecology and dietary habits of *Lachesis* taxa in the wild is scarce and limited to only some species of the genus ([@bib30]; [@bib146]; [@bib158]; [@bib173]; [@bib192]), and a good number of reports are derived from observations of specimens in captivity ([@bib18]; [@bib36]; [@bib44]; [@bib147]; [@bib175]). This is, in part, due to the challenge of observing these snakes in their natural habitats in remote tropical moist forested areas where, except during breeding activities, bushmasters are solitary crepuscular or nocturnal predators ([@bib30]). The limited work conducted on bushmaster species suggests these snakes are dependent on several specific resources and are thus particularly susceptible to disturbance. Hence, due to habitat destruction, the population density of *Lachesis* taxa has decreased worryingly to the point that *L. muta. ssp. rhombeata*, which exhibits the broadest range in the Amazon region of Brazil and surrounding countries, is listed as vulnerable according to the IUCN Red List of Threatened Species criteria and considered endangered throughout its range ([@bib99]). Habitat loss, pollution and poaching are the main reasons for its decline. At the other extreme, the Atlantic bushmaster L. *m. rhombeata*, a species endemic to Brazil, has a very restricted distribution that is becoming increasingly fragmented through deforestation for using the cleared areas for agriculture and human settlements ([@bib123]). Another species, the black-headed bushmaster *L. melanocephala*, inhabits also a very small geographic range, including tropical, premontane and montane humid, very humid, and pluvial forests. The limited work that has been conducted on this bushmaster species suggests that it is particularly susceptible to disturbance ([@bib173]). Due to its restricted geographic range and habitat specificity, the severe and continued loss of lowland and mid-elevation forests throughout its range pose serious threats to the persistence of the endemic black-headed bushmaster in Costa Rica and Panamá ([@bib83]). The paucity of information on *L. melanocephala*, which is due in large part to its cryptic nature spending much time underground and its occurrence at low densities, prevents any effective conservation actions for this species.

Omic technologies, including comparative genomics across the reptile phylogeny along with paleogeographic niche reconstruction, can provide important insights into the ecological factor and evolutionary pressures that shaped the explosive diversification of many species-rich clades, including caenophidian snakes, in the wake of the Cretaceous-Paleogene (K-Pg) Mass Extinction 66 Mya, when a massive asteroid struck the Earth, brought a calamitous end to the reign of dinosaurs, and account for the loss of 75 percent of known species ([@bib7]; [@bib87]). The K-Pg global mass extinction event left numerous ecological niches vacant creating new ecological opportunities ([@bib70]; [@bib98]; [@bib122]; [@bib140]; [@bib168]). Although some aspects of the phylogeny of some clades within the medically important snake families Viperidae, Elapidae, and Colubridae are still under dispute, in general, their phylogenetic relationships and time of divergence between lineages are well supported from fossil and molecular (nuclear and mitochondrial gene) information ([@bib5]; [@bib141]; [@bib143]; [@bib191]). Venom emerged as a key evolutionary innovation that underpinned the explosive radiation of caenophidian snakes. A reliable phylogeny is key to establishing the evolutionary trends that have shaped the patterns of venom across the speciation of a clade of snakes.

An increasing trend in venom analysis is the identification of evolutionary trends across whole genera, taxonomic clades, and phylogenetic families. The overall picture, rather than the individual venom proteomes, provides hints for reconstructing the origin of evolutionary trends ([@bib23], [@bib24]). *Lachesis* represents one of the few snake genus for which the venom proteomes of all its species have been unveiled. Mapping the pattern of present-day venom variability into a phylogenetic and biogeographic framework may lay the foundation for understanding the evolutionary trends that have shaped the venomic landscape across the clade. In addition, the genome also encodes traces from both functionally-failed recombinations and those that passed the natural selection filter and contributed to the functional genome of the species ([@bib104]; [@bib107]; [@bib109]; [@bib131]; [@bib132]; [@bib133]; [@bib144]; [@bib160]). The development of comparative genomics in the last 20 years has taught us that no lineage can be studied genomically in isolation from related lineages. However, despite the genomes of birds and nonavian reptiles will not only uncover a treasure trove of biological information to reconstruct the evolution of venomous reptiles and their venom genes, but are also critical for understanding genome evolution in mammals and amniotes generally ([@bib101]; [@bib180], [@bib179]), snake genome sequencing is in its infancy. Squamates exhibit some of the most extreme and fascinating biological adaptations among vertebrates ([@bib162]). However, genomic resources are currently only available for a handful of squamous reptiles ([@bib6]; [@bib34]; [@bib81]; [@bib85]; [@bib103]; [@bib107]; [@bib109]; [@bib132]; [@bib160]; [@bib163]; [@bib176]; [@bib179]; [@bib181]; [@bib182]; [@bib190]). Comparative Squamata omics (genomics, transcriptomics, and proteomics) will play a fundamental role in filling this gap and addressing the connection between genome evolution and the present-day adaptive phenotype for fitness related traits ([@bib35]; [@bib63]; [@bib66]; [@bib96]).

The wide spectrum of pathological and pathophysiological manifestations of snake envenomings, due to the concerted actions of the unpredictable venom variability across the phylogeny and distribution range of extant snakes, represents a great challenge for the development, and preclinical evaluation of the efficacy of antivenoms. From a biotechnological stand point, this goal requires knowing the phylogeographical patterns of present-day snake venoms, identifying their most medically-important molecules in the context of a human envenoming, and assessing the specific and para-specific efficacy of current antivenoms against the different medically relevant snake venoms. For the case of genus *Lachesis,* the high conservation of the overall composition of Central and South American bushmaster venoms provides the ground for rationalizing the "*Lachesis syndrome*\" documented in envenomings by different species of this wide-ranging genus. From an evolutionary ecology perspective legitimate human snake envenomings result from defensive bites inflicted by sympatric venomous snakes when snake and human have a fortuitous encounter in their shared natural environment that blows the snake\'s alarms. In this context, knowledge gained on the natural history and organismal physiology of medically important snakes, particularly those that prey on mammals, have conceptually applicability in clinical toxinology as in the ecological context, highlighting the mutually enlightening relationship between evolutionary and translational venomics ([@bib197]).

Clearly, we believe that it is not an exaggeration to conclude that our field, molecular toxinology, has a very exciting future ahead. We trust this short review on the bushmasters may help to put this genus of medically and ecologically relevant snakes in the spotlight of near future basic and applied developments.
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